Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Budget Talks

Budget Expert: ACA Tax Credits Would Be Absorbed Into Baseline Under ‘Current Policy’ Assumptions

If Republicans choose to use the “current policy” Congressional Budget Office (CBO) baseline to presume the 2017 tax cuts continue for the next decade instead of expiring in December, which eliminates the need to offset that spending, it would similarly extend the Affordable Care Act’s premium tax credits that have the same expiration date, Bipartisan Policy Center Senior Vice President G. William Hoagland told Inside Health Policy.

Wyden, Schumer: Senate Budget Resolution Puts Health Care In Crosshairs

Transition 2025

FDA Workers Verbally Mandated To Return To Office, Might Avoid Opposing Decisions For Fear Of Reprisal

FDA supervisors were directed to only verbally tell their employees Thursday (Feb. 6) they must work in person five days a week beginning in March and not put the messages in writing amid the growing chaos surrounding the Trump administration’s efforts to dramatically downsize federal agencies and scrub regulatory policies not in sync with the new president’s.

Stakeholders Cling Onto Trump’s Medicaid ‘Love’ Statement In Bid To Quash GOP Cuts

Health Care NGOs Brace For Impact As Admin Orders Funding Review

More Coverage →

Latest News

Telehealth company Hims & Hers Health is set to air its first Super Bowl ad Sunday (Feb. 9), promoting compounded weight-loss drugs -- sparking allegations from a bipartisan Senate duo, the Pharmaceutical Research and Manufacturers of America (PhRMA) and a public health group that the ad is misleading and goes against the intent of FDA’s prescription drug advertising rules.

FDA events are continuing to be postponed or canceled after the end date of the agency’s originally announced communications pause, including events in late January such as a webinar on FDA’s new “healthy” standard for food products and a meeting with Health Canada on international device standards.

AMELIA ISLAND, FL -- Tariffs won’t be enough to bring generic drug and active pharmaceutical ingredient (API) manufacturing to the United States, generic advocates said at the Association for Accessible Medicines (AAM) conference this week, despite the Trump administration’s tough trade policy.